{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:17:53Z","timestamp":1792729073594,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007177","name":"CRC Health Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007177","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019286","name":"Ajman University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019286","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.sapharm.2024.12.006","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T17:26:36Z","timestamp":1734110796000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Community pharmacist-led point-of-care colorectal cancer screening program: Early detection of colorectal cancer in high-risk patients"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-0878","authenticated-orcid":false,"given":"Ammar Abdulrahman","family":"Jairoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabaa Saleh","family":"Al-Hemyari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moyad","family":"Shahwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samer H.","family":"Zyoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar Ali","family":"Saleh Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2024.12.006_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.sapharm.2024.12.006_bib2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.13005\/bpj\/1548","article-title":"The prevalence and evolving risk factors for colorectal cancer in the Arab World","volume":"11","author":"Guraya","year":"2018","journal-title":"Biomed Pharmacol J"},{"key":"10.1016\/j.sapharm.2024.12.006_bib3","first-page":"109","article-title":"Colorectal cancer incidence patterns in the United States, 1974-2013","author":"Siegel","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.sapharm.2024.12.006_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/archinternmed.2011.602","article-title":"Young-onset colorectal cancer: is it time to pay attention?","volume":"172","author":"You","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sapharm.2024.12.006_bib5","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.clcc.2018.10.002","article-title":"Rising proportion of young individuals with rectal and colon cancer","volume":"18","author":"Kasi","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.sapharm.2024.12.006_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.sapharm.2024.12.006_bib7","first-page":"11","article-title":"BobicSJCeTV. The impact of environmental factors upon the incidence rate of colorectal cancer","volume":"30","author":"P\u0103un","year":"2015","journal-title":"Ci\u00eancia T\u00e9cnica Vitivin\u00edcola"},{"issue":"11","key":"10.1016\/j.sapharm.2024.12.006_bib8","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4251\/wjgo.v13.i11.1791","article-title":"Colorectal cancer in Arab world: a systematic review","volume":"13","author":"Makhlouf","year":"2021","journal-title":"World J Gastrointest Oncol"},{"issue":"7","key":"10.1016\/j.sapharm.2024.12.006_bib9","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.3390\/cancers14071732","article-title":"Colorectal cancer: a review of carcinogenesis, global epidemiology, current challenges, risk factors, preventive and treatment strategies","volume":"14","author":"Hossain","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.sapharm.2024.12.006_bib10","series-title":"Colorectal Cancer Screening. IARC Handbooks of Cancer Prevention","year":"2019"},{"key":"10.1016\/j.sapharm.2024.12.006_bib11","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1001\/jama.2016.5989","article-title":"Screening for colorectal cancer: US preventive services task force recommendation statement","volume":"315","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.sapharm.2024.12.006_bib12","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3748\/wjg.v23.i20.3632","article-title":"Colorectal cancer population screening programs worldwide in 2016: an update","volume":"23","author":"Navarro","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.sapharm.2024.12.006_bib13","series-title":"Cancer Screening in the European Union. Report on the Implementation of the Council Recommendation on Cancer Screening","year":"2017"},{"key":"10.1016\/j.sapharm.2024.12.006_bib14","first-page":"21","article-title":"Colorectal cancer: evolution of screening strategies","volume":"92","author":"Sur","year":"2019","journal-title":"Med. Pharm. Rep."},{"issue":"2 Suppl. 1","key":"10.1016\/j.sapharm.2024.12.006_bib15","first-page":"25","article-title":"The role of the Community Pharmacist in promoting vaccinations among general population according to the National Vaccination Plan 2017-2019: results from a survey in Sicily, Italy","volume":"31","author":"Scarpitta","year":"2019","journal-title":"Ann Ig Med Preventiva Comunita"},{"key":"10.1016\/j.sapharm.2024.12.006_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ypmed.2019.04.003","article-title":"The effects of community pharmacy-delivered public health interventions on population health and health inequalities: a review of reviews","volume":"124","author":"Thomson","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/j.sapharm.2024.12.006_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.canep.2015.07.011","article-title":"Promoting the early detection of cancer: a systematic review of community pharmacy-based education and screening interventions","volume":"39","author":"Lindsey","year":"2015","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.sapharm.2024.12.006_bib18","first-page":"274","article-title":"The community pharmacist's role in cancer screening and prevention","volume":"149","author":"Havlicek","year":"2016","journal-title":"Can Pharm J. Rev des Pharm du Can."},{"issue":"144","key":"10.1016\/j.sapharm.2024.12.006_bib19","first-page":"41","article-title":"Epidemiology of colorectal cancer: incidence, mortality, survival rates and risk factors","volume":"23","author":"RahimiPordanjani","year":"2016","journal-title":"Razi J Med Sci"},{"issue":"8","key":"10.1016\/j.sapharm.2024.12.006_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2017.37","article-title":"Selecting a cut-off for colorectal cancer screening with a fecal immunochemical test","volume":"8","author":"Brenner","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"issue":"10","key":"10.1016\/j.sapharm.2024.12.006_bib21","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1136\/gutjnl-2022-327985","article-title":"Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the British Society of Gastroenterology (BSG)","volume":"71","author":"Monahan","year":"2022","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.sapharm.2024.12.006_bib22","article-title":"Interpretation of faecal haemoglobin concentration data in colorectal cancer screening and in assessment of symptomatic patients","volume":"2","author":"Fraser","year":"2017","journal-title":"Journal of Laboratory and Precision Medicine"},{"issue":"6","key":"10.1016\/j.sapharm.2024.12.006_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1470-2045(11)70101-2","article-title":"Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort","volume":"12","author":"Chen","year":"2011","journal-title":"The lancet oncology"},{"key":"10.1016\/j.sapharm.2024.12.006_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2021.106420","article-title":"Role of community pharmacies in a population-based colorectal cancer screening program","volume":"145","author":"Vives","year":"2021","journal-title":"Prev Med"},{"key":"10.1016\/j.sapharm.2024.12.006_bib25","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.sapharm.2024.12.006_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1440-1746.2009.05790.x","article-title":"Colorectal cancer in inflammatory bowel disease","volume":"24","author":"Leong","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.sapharm.2024.12.006_bib27","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/apt.12651","article-title":"Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis","volume":"39","author":"Casta\u00f1o-Milla","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.sapharm.2024.12.006_bib28","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/gutjnl-2013-304701","article-title":"Obesity and colorectal cancer","volume":"62","author":"Bardou","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.sapharm.2024.12.006_bib29","article-title":"Obesity and risk of colorectal cancer: a systematic review of prospective studies","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.sapharm.2024.12.006_bib30","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3390\/jcm12072451","article-title":"Why does obesity as an inflammatory condition predispose to colorectal cancer?","volume":"12","author":"Rychter","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.sapharm.2024.12.006_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001988","article-title":"A nested case-control study of metabolically defined body size phenotypes and risk of colorectal cancer in the European prospective investigation into cancer and nutrition (EPIC)","volume":"13","author":"Murphy","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.sapharm.2024.12.006_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2407-11-20","article-title":"Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals","volume":"11","author":"Lee","year":"2011","journal-title":"BMC Cancer"},{"key":"10.1016\/j.sapharm.2024.12.006_bib33","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10552-012-0095-7","article-title":"Racial disparities in colorectal cancer incidence by type 2 diabetes mellitus status","volume":"24","author":"Cavicchia","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.sapharm.2024.12.006_bib34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/MEG.0000000000000626","article-title":"Diabetes mellitus type 2 and subsite-specific colorectal cancer risk in men and women: results from The Netherlands Cohort Study on diet and cancer","volume":"28","author":"de Kort","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.sapharm.2024.12.006_bib35","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s10620-012-2059-x","article-title":"Diabetes mellitus is an independent risk factor for colorectal cancer","volume":"57","author":"Sun","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.sapharm.2024.12.006_bib36","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/dc14-1175","article-title":"The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity","volume":"38","author":"Peeters","year":"2015","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.sapharm.2024.12.006_bib37","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/s41416-018-0314-4","article-title":"Type 2 diabetes and risk of colorectal cancer in two large U.S. prospective cohorts","volume":"119","author":"Ma","year":"2018","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.sapharm.2024.12.006_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102828","article-title":"Association of diabetes mellitus with early-onset colorectal cancer: a systematic review and meta-analysis of 19 studies including 10 million individuals and 30,000 events","volume":"17","author":"Khoa Ta","year":"2023","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"key":"10.1016\/j.sapharm.2024.12.006_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/BF00052777","article-title":"Insulin and colon cancer","volume":"6","author":"Giovannucci","year":"1995","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.sapharm.2024.12.006_bib40","doi-asserted-by":"crossref","first-page":"18456","DOI":"10.18632\/oncotarget.14472","article-title":"2017 update on the relationship between diabetes and colorectal cancer: epidemiology, potential molecular mechanisms and therapeutic implications","volume":"8","author":"Gonz\u00e1lez","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.sapharm.2024.12.006_bib41","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1001\/jamaoncol.2020.7338","article-title":"Aspirin use and risk of colorectal cancer among older adults","volume":"7","author":"Guo","year":"2021","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.sapharm.2024.12.006_bib42","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"U.S. Preventive Services Task Force. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.sapharm.2024.12.006_bib43","first-page":"477","article-title":"Navigating the murky waters of colorectal cancer screening and follow-up","volume":"14","author":"Green","year":"2016","journal-title":"Ann Fam Med"},{"issue":"4","key":"10.1016\/j.sapharm.2024.12.006_bib44","first-page":"330","article-title":"Pharmacists' role in promoting colorectal cancer screening: a systematic review","volume":"27","author":"Sullivan","year":"2019","journal-title":"Int J Pharm Pract"},{"issue":"4","key":"10.1016\/j.sapharm.2024.12.006_bib45","first-page":"560","article-title":"Comparing pharmacist-led and physician-led colorectal cancer screening: a randomized trial","volume":"58","author":"Patel","year":"2020","journal-title":"Am J Prev Med"},{"issue":"3","key":"10.1016\/j.sapharm.2024.12.006_bib46","first-page":"543","article-title":"Community pharmacists and colorectal cancer screening: an integrative review","volume":"36","author":"Jackson","year":"2021","journal-title":"J Cancer Educ"},{"issue":"1","key":"10.1016\/j.sapharm.2024.12.006_bib47","article-title":"\u2018The gatekeepers in prevention\u2019: community pharmacist perceptions of their role in the opioid epidemic","volume":"43","author":"Vadiei","year":"2022","journal-title":"Subst Use Misuse"},{"issue":"4, Supplement","key":"10.1016\/j.sapharm.2024.12.006_bib48","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.japh.2022.11.012","article-title":"Assessing the effects of pharmacist education on colorectal cancer screening and access to a stool-based DNA test","volume":"63","author":"Moore","year":"2023","journal-title":"J Am Pharmaceut Assoc"},{"issue":"6","key":"10.1016\/j.sapharm.2024.12.006_bib49","first-page":"882","article-title":"Pharmacist-led interventions to increase colorectal cancer screening rates: a meta-analysis","volume":"26","author":"Thakkar","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.sapharm.2024.12.006_bib50","doi-asserted-by":"crossref","DOI":"10.1111\/jocn.16189","article-title":"Colorectal cancer survivors' experience of continuity of care provided by different health professionals: a qualitative evidence synthesis","author":"Wang","year":"2022","journal-title":"J Clin Nurs"},{"issue":"5","key":"10.1016\/j.sapharm.2024.12.006_bib51","first-page":"361","article-title":"The role of pharmacists in colorectal cancer screening: an evidence-based review","volume":"24","author":"Smith","year":"2018","journal-title":"J Oncol Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2024.12.006_bib52","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/ijerph17020536","article-title":"The community pharmacist: perceived barriers and patient-centered care communication","volume":"17","author":"Ilardo","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"issue":"4","key":"10.1016\/j.sapharm.2024.12.006_bib53","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.japh.2020.02.014","article-title":"Pharmacist intervention in colorectal cancer screening initiative","volume":"60","author":"Holle","year":"2020","journal-title":"J Am Pharmaceut Assoc"},{"key":"10.1016\/j.sapharm.2024.12.006_bib54","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10552-023-01687-x","article-title":"Patient preferences for the design of a pharmacy-based colorectal cancer screening program","volume":"34","author":"Brenner","year":"2023","journal-title":"Cancer Causes & Control"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124004108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124004108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T10:56:53Z","timestamp":1738148213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741124004108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1551741124004108"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.12.006","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Community pharmacist-led point-of-care colorectal cancer screening program: Early detection of colorectal cancer in high-risk patients","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}